Recent advances in targeting cancer stem cells using oncolytic viruses

Area of Science:

• Oncology
• Virology
• Cancer Stem Cell Biology

Background:

• Oncolytic virotherapy utilizes viral replication to induce cancer cell death and stimulate anti-tumor immune responses.
• Cancer stem cells (CSCs) are implicated in tumor metastasis and resistance to conventional therapies.
• Targeting CSCs is crucial to prevent tumor recurrence and poor prognosis.

Purpose of the Study:

• To review the oncolytic activity of various oncolytic viruses (OVs) against different types of cancer stem cells.
• To discuss the synergistic effects of combining OVs with traditional therapies for chemo- and radiotherapy-resistant CSCs.

Main Methods:

• Literature review of oncolytic virotherapy studies.
• Analysis of OV mechanisms targeting cancer stem cells.
• Evaluation of combination therapies involving OVs and conventional treatments.

Main Results:

• Oncolytic viruses demonstrate efficacy in targeting and eliminating cancer stem cells across various cancer types.
• Engineered OVs with inserted anticancer genes show augmented oncolytic capacity.
• Combination strategies involving OVs and traditional therapies can overcome resistance in cancer stem cells.

Conclusions:

• Oncolytic virotherapy presents a promising strategy for eradicating cancer stem cells, a key factor in tumor progression and treatment resistance.
• The combination of oncolytic viruses with conventional therapies offers a synergistic approach to combat chemo- and radiotherapy-resistant cancers.